. . . . . . . "[This study evaluated the efficacy and safety of ATL1102, an antisense oligonucleotide that selectively targets the RNA for human CD49d, the ? subunit of very late antigen 4, in patients with relapsing-remitting multiple sclerosis (RRMS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:01+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .